Why is Windlas Biotech falling/rising?

As of 07-Nov, Windlas Biotech Ltd is experiencing a decline in its stock price, currently at Rs 867.80, which represents a decrease of Rs 56.2 or 6.08%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 9.66% during this period. It opened with a loss of 2.6% today and reached an intraday low of Rs 855, reflecting a 7.47% drop. In terms of performance over the past week, the stock has decreased by 7.89%, while its year-to-date return stands at a negative 16.03%. Despite positive quarterly results showing the highest net sales and operating profit margins, the stock's overall performance has been hindered by poor long-term growth and significant underperformance relative to the broader market.
In the broader market context, Windlas Biotech's recent performance contrasts sharply with the Sensex, which has gained 1.57% over the past month. The stock's negative return of 4.87% over the last month further emphasizes its struggle against the benchmark. While the company has a low debt-to-equity ratio and has seen a rise in investor participation, these factors have not been sufficient to counterbalance the negative sentiment surrounding its long-term growth prospects. The stock's trading below all major moving averages indicates a bearish trend, and its significant underperformance over the last year, where it has generated a return of -19.20% compared to the market's positive returns, suggests a lack of investor confidence.